Correspondence on 'H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma' by Immisch .
作者信息
Chheda Zinal S, Mueller Sabine, Hegde Bindu, Yamamichi Akane, Butterfield Lisa H, Okada Hideho
机构信息
Sanofi Genzyme, Cambridge, Massachusetts, USA.
Department of Neurology, UCSF, San Francisco, California, USA.
出版信息
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-006617.
Abstract
摘要
Zotero 插件